Related Experiment Video
Updated: Jan 12, 2026

03:37
Intravitreal Injections in the Ovine Eye
Published on: July 5, 2022
3.9K
A Case Series of Serious Adverse Events Following Anti-VEGF Intravitreal Injections
Andreea Alexandra Mihaela Muşat1,2, Nicoleta Zamfiroiu-Avidis2, Cornel Ştefan3
1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Romanian Journal of Ophthalmology
|November 5, 2025
Summary
Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy can cause serious adverse effects like endophthalmitis and cataract. Vigilance in patient selection and risk-benefit assessment is crucial for safe treatment of retinal diseases.
Area of Science:
- Ophthalmology
- Retinal Diseases
- Medical Interventions
Background:
- Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy is a standard treatment for many retinal diseases.
- Despite its efficacy, potential serious adverse effects require careful consideration.

